According to statistics from the National Health and Family Planning Commission, the current incidence of lung cancer in my country is increasing at an annual rate of 26.9%. In recent decades, the number of lung cancer patients has doubled every 10 to 15 years. The results of the third survey of causes of death among residents in my country also show that lung cancer mortality has increased by 465% in the past 30 years, replacing liver cancer as the malignant tumor with the highest mortality rate in China.
Facing such a rapidly growing group of lung cancer patients, I have a deep understanding! In late September 2013, my mother called me suddenly and told me that my father had been diagnosed with non-small cell lung adenocarcinoma the day before. It was like a thunderbolt in the clear sky, and I couldn't believe it was true: "God! Why did my dearest dad have a terminal illness!"
Taking advantage of the National Day holiday, I hurried back home. What makes me gratified is that my father is still so tough and looks good. It's just that his voice is no longer able to speak, and his expression is obviously more depressed. I kept encouraging my father, but my father just smiled most of the time. In fact, he should know a lot of things better than us. Of course, hope remains.
On October 8, his father, accompanied by his family, went to the hospital. Surgery was soon performed, and then chemotherapy was performed. After the first course of chemotherapy was over, considering the inconvenience of taking care of his father, he adopted the method chosen by most families: returning to the county where he was home to continue the treatment.
Later, I heard a doctor's introduction that I also bought small-molecule targeted drugs for my father. The price of the drugs put me under pressure. But for the sake of my father, I must persist in suffering! When I saw my father again, I felt extremely uncomfortable: all the black hair on my father's head had fallen off, and he was weak and looked at least ten years old. The father who used to be full of spirits will never be seen again.
In April 2014, his father was reviewed at the hospital. The results of CT examination showed that no obvious tumors were found in both lungs of the father. Blood tests are also normal. As soon as the news came out, our family was very happy and felt that all the efforts were worthwhile. But this joyful time is always too short. In February 2015, my mother called and told me that due to my father’s recent cough and chest tightness, he went to the hospital for an examination and found that the lung cancer had recurred and brain metastases had occurred. "At this time, I remembered that a doctor friend said to me that chemotherapy will significantly reduce lung cancer lesions, or even disappear, but relapse quickly. Although small-molecule targeted drugs are effective, they usually appear resistant within 9-12 months. The medicine fails.
My father's condition relapsed. Although I was very sad, I did not give up the hope of finding an effective treatment for my father. Later, I went to a well-known cancer specialist hospital to consult a doctor. The doctor carefully reviewed my father’s medical records and suggested that my father received ACTL targeted cellular immunotherapy. The doctor told me that surgery, chemotherapy, radiotherapy and biological therapy are the four major treatment methods of contemporary anti-tumor therapy. Cellular immunotherapy is one of the most important components of biological therapy. ACTL treatment is a typical precision medical technology, which is safe and reliable, without toxic side effects, and can accurately identify and kill cancer cells, but has no killing effect on normal tissue cells. It can also delay or even prevent the occurrence of drug resistance of small molecule targeted drugs for the treatment of lung cancer, and significantly improve the quality of life. After listening to the doctor's introduction, I felt as if I had caught a life-saving straw, and in despair I saw possible hope.
In response to my father's condition, the doctor formulated an ACTL targeted cellular immunotherapy program for him twice a month. After 6 treatments, serum tumor markers returned to normal. Imaging report: no new lesions were found, and brain metastases were significantly reduced. The following is a picture of the situation before and after treatment:
Seeing my father miraculously improved again, I was ecstatic. After ACTL targeted cellular immunotherapy, his father, who was declared to be only alive for more than three months at the time, is now more and more healthy after two years, and he is gradually regaining his vigor. And I have a very good appetite and I have gained weight. Here, I want to thank the doctor and all those who helped us. Thank you!
